Results 241 to 250 of about 57,164 (280)

Ensitrelvir in Hospitalized Patients with SARS-CoV-2 During the Omicron Epidemic: A Single-Center Observational Study. [PDF]

Infect Dis Ther
Yamato M, Kinoshita M, Yoshida Y, Yamamoto Y, Izuhara R, Sonoyama T.   +5 more
europepmc   +1 more source

Efficacy of oral remdesivir in treating feline infectious peritonitis: a prospective observational study of 29 cats. [PDF]

J Feline Med Surg
Renner KA, Cattin R, Kimble B, Munday J, White A, Coggins S.   +5 more
europepmc   +1 more source

Efficacy of GS-441524 for Feline Infectious Peritonitis: A Systematic Review (2018-2024). [PDF]

Pathogens
Gokalsing E, Ferrolho J, Gibson MS, Vilhena H, Anastácio S.   +4 more
europepmc   +1 more source

In Search for Effective and Safe Drugs Against SARS-CoV-2: Part III] the Electronic Factors of Remdesivir and the Naturally Extracted Aspirochlorine Drugs

, 2020
M. S. A. Abdel‐Mottaleb, Yousra Abdel–Mottaleb   +1 more
openalex   +1 more source

A systemic approach to estimate and validate RP-HPLC assay method for remdesivir and favipiravir in capsule dosage form. [PDF]

PLoS One
Khan NU, Iqbal M, Khan BA.
europepmc   +1 more source

ANTI HEPATITIS C VIRAL DRUGS REMDESIVIR AND UPRIFOSBUVIR DERIVATIVES ARE BETTER INHIBITORS OF SARS COV2 RNA-DEPENDENT RNA POLYMERASE DETERMINED BY DOCKING.

, 2020
Pavan Gudipati, Shyamasri Biswas, Pankaj Goyal   +2 more
openalex   +1 more source

Effectiveness and Safety of Remdesivir for the Treatment of COVID-19 Patients with Liver Cirrhosis: A Retrospective Cohort Study. [PDF]

Life (Basel)
Wong YC, Ng CJ, Huang YB, Chen SY.
europepmc   +1 more source

Remdesivir-Bound and Ligand-Free Simulations Reveal the Probable Mechanism of Inhibiting the RNA Dependent RNA Polymerase of SARS-CoV-2

, 2020
Shruti Koulgi, Vinod Jani, Mallikarjunachari Uppuladinne V N, Uddhavesh Sonavane, Rajendra Joshi   +4 more
openalex   +1 more source

Evolution of Antiviral Drug Resistance in SARS-CoV-2. [PDF]

Viruses
Dinata R, Baindara P, Mandal SM.
europepmc   +1 more source